These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2005-003520-18||Multicenter, double-blind placebo controlled study of levetiracetam in the treatment of childhood and juvenile absence epilepsy.||bad-data|
|Completed, but no date||2005-003522-26||Open label, multicenter study of levetiracetam in the treatment of childhood and juvenile absence epilepsy||bad-data|
|Ongoing||2007-003702-95||A MULTICENTRE RANDOMIZED CONTROLLED TRIAL COMPARING TOPIRAMATE, STIRIPENTOL AND CLOBAZAM AS ADJUNCTIVE THERAPY TO VALPROATE AND CLOBAZAM IN PAEDIATRIC PATIENTS WITH DRAVET'S SYNDROME (SMEI) NOT ADEQUA...||not-yet-due|
|Ongoing||2008-000955-90||Randomized, single-blind, clinical and MRI study for evaluation of safety and efficacy of N-Acetyl Cysteine (NAC) associated with high-dose beta-Interferon in Relapsing-Remitting (RR) multiple sclero...||not-yet-due|
|Ongoing||2008-007162-32||ADVANCED MRI STUDY ON INFLAMMATORY AND DEGENRATIVE DAMAGE IN MULTIPLE SCLEROSIS||not-yet-due|
|Ongoing||2012-001017-16||A randomized controlled trial of generic substitution of antiepileptic drugs||not-yet-due|
|Ongoing||2014-004650-34||Neuromodulation strategies to enhance the effects of gait rehabilitation in multiple sclerosis patients with cerebellar ataxia||not-yet-due|